Newsfile
Search documents
BluMetric Files Final Base Shelf Prospectus
Newsfile· 2025-11-19 22:00
Core Viewpoint - BluMetric Environmental Inc. has received approval for its final short form base shelf prospectus, allowing it to raise up to $50 million in securities over a 25-month period [1][2]. Group 1: Prospectus Details - The final base shelf prospectus enables the company to distribute up to $50 million of common shares, securities, warrants, subscription receipts, units, or a combination thereof [2]. - Specific terms for any offerings under the base shelf prospectus will be detailed in a prospectus supplement, which will be filed with Canadian securities regulatory authorities [2][3]. - The shelf prospectus will facilitate access to new capital or securities issuance for strategic acquisitions as needed, with the timing and amount based on financial requirements and market conditions [3]. Group 2: Company Overview - BluMetric Environmental Inc. is a publicly traded firm specializing in water technology and environmental engineering, with over 230 employees across 11 offices and 3 manufacturing facilities [6]. - The company has a history of over 50 years and serves various sectors including Commercial and Industrial, Government, Military, and Mining clients [6]. Group 3: Board Compensation - The company has granted options for 30,000 common shares to a Board Member, effective October 29, 2025, with a vesting period of two years and an exercise price of $1.46 per share for seven years [5].
Allied Critical Metals Announces Material Increase to Mineral Resource Estimate at Borralha Tungsten Project in Northern Portugal
Newsfile· 2025-11-19 22:00
Core Viewpoint - Allied Critical Metals Inc. has announced a significant increase in the Mineral Resource Estimate (MRE) for its Borralha Tungsten Project in Northern Portugal, which is expected to advance towards a Preliminary Economic Assessment (PEA) targeted for Q1 2026, amid strong tungsten prices and increasing demand for critical raw materials [3][4][6]. Mineral Resource Estimate Update - The updated MRE for the Borralha Tungsten Project shows a substantial increase to 13.0 million tonnes Measured and Indicated (M+I) at 0.21% WO₃ and 7.7 million tonnes Inferred at 0.18% WO₃, compared to the previous estimate of 4.98 million tonnes Indicated at 0.21% WO₃ and 7.01 million tonnes Inferred at 0.20% WO₃ [4][6]. - The MRE is based on a cut-off grade of 0.09% WO₃ and does not include other potential mineralized deposits on the property [5][6]. Geological and Metallurgical Context - The Santa Helena Breccia is confirmed as a large, mineralized system with strong structural control and excellent lateral continuity, indicating significant potential for further resource growth [9][10]. - Existing metallurgical programs suggest a simple, low-cost gravity flowsheet with a recovery rate of approximately 75-85% WO₃, with potential by-products including copper, tin, and silver [10][11]. Strategic Importance - The Borralha Project is positioned as a critical asset in Europe, especially given the EU's reliance on tungsten imports from China, with over 80% of its tungsten supply coming from there [24][25]. - The project is aligned with the EU Critical Raw Materials Act and NATO strategic autonomy initiatives, emphasizing its importance in developing a secure domestic supply of tungsten [24][25]. Next Steps - The company plans to conduct further drilling campaigns in early 2026 to expand the resource base and support the upcoming PEA [7][12]. - Ongoing environmental and hydrogeological baseline programs are in place to facilitate the permitting process, with anticipated approvals expected in Q1 2026 [7][12].
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Newsfile· 2025-11-19 21:30
Core Viewpoint - SureNano Science Ltd. has entered into a non-binding letter of intent with GlucaPharm Inc. to explore a proposed transaction for the development of a GLP-1 drug, GEP-44, which targets diabetes and weight loss with a no-needle administration method and improved tolerability [1][2] Proposed Transaction Overview - The proposed transaction is structured as a share exchange, where SureNano will acquire 100% of GlucaPharm's common shares, with GlucaPharm shareholders expected to own under 20% of SureNano's shares post-transaction [3][4] - The transaction is subject to customary due diligence, negotiation of a definitive agreement, and necessary regulatory approvals [4] GlucaPharm's Product Details - GlucaPharm holds exclusive rights to develop GEP-44, a novel GLP-1 compound that aims to improve treatment for obesity and diabetes, showing strong preclinical results and academic validation [2] Private Placement - SureNano announced a private placement to raise up to $1,250,000 by selling up to 10,000,000 units at $0.125 per unit, with each unit consisting of one common share and one warrant [6][7] - Proceeds from the private placement will be used for operating expenses, including legal fees and market exploration, and are not dependent on the acquisition of GlucaPharm [8] Company Background - SureNano Science Ltd. specializes in the sale and distribution of the SureNano™ surfactant, which enhances the performance of nanoemulsions, and holds exclusive distribution rights in Canada and certain U.S. states [9]
Ivanhoe Electric Makes Final Land Acquisition Payment at the Santa Cruz Copper Project in Arizona
Newsfile· 2025-11-19 21:30
Core Insights - Ivanhoe Electric has completed the final three land acquisition payments totaling $39.3 million for the Santa Cruz Copper Project in Arizona, fulfilling the terms of the Purchase and Sale Agreement with Wolff-Harvard Ventures LLC [1][2] - The company is positioned to commence initial construction at the Santa Cruz project in early 2026, pending the receipt of necessary permits, with a goal of first copper cathode production by late 2028 [2][6] Company Overview - Ivanhoe Electric is a U.S.-based minerals exploration company focused on developing mines from mineral deposits primarily located in the United States, aiming to support American supply chain independence by delivering copper and other critical metals [2] - The company utilizes its Typhoon™ geophysical surveying system and advanced data analytics from its subsidiary, Computational Geosciences Inc., to enhance the mineral exploration process [2] - Ivanhoe Electric also operates a joint venture with Saudi Arabian Mining Company to explore minerals in the Arabian Shield and has established an exploration alliance with BHP Mineral Resources Inc. to search for critical minerals in the U.S. [2]
CSE Bulletin: Notice of Distribution - Linear Minerals Corp. (LINE)
Newsfile· 2025-11-19 21:20
Core Points - Linear Minerals Corp. has announced a share distribution record date of November 25, 2025, as part of a Plan of Arrangement with Westlinear Minerals Corp. dated August 1, 2025 [1][3] - Shareholders of Linear will receive one share of Westlinear for every 10 shares of Linear owned on the Share Distribution Record Date [1][3] - Holders of Linear options and warrants who exercise them before the Share Distribution Record Date will also be entitled to the same share distribution [2][4] Additional Details - The information circular detailing the Arrangement was dated August 28, 2025 [2][4] - The ex-distribution date is also set for November 25, 2025 [5]
FCX INVESTOR ALERT: Freeport McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile· 2025-11-19 21:05
San Diego, California--(Newsfile Corp. - November 19, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Freeport-McMoRan Inc. (NYSE: FCX) publicly traded securities between February 15, 2022 and September 24, 2025, both dates inclusive (the "Class Period"), have until January 12, 2026 to seek appointment as lead plaintiff of the Freeport-McMoRan class action lawsuit. Captioned Reed v. Freeport-McMoRan Inc., No. 25-cv-04243 (D. Ariz.), the Freeport-McMoRan class action lawsu ...
Volt Carbon Technologies Announces Final Closing of Private Placement for Gross Proceeds of $300,000
Newsfile· 2025-11-19 21:00
Core Viewpoint - Volt Carbon Technologies has successfully completed the final tranche of its private placement, raising a total of $300,000 to support its operations and development initiatives [1][4]. Group 1: Private Placement Details - The final tranche involved the issuance of 6,000,000 units at a price of $0.025 per unit, generating gross proceeds of $150,000 [2]. - Combined with the first tranche, which also consisted of 6,000,000 units, the total gross proceeds from the offering amount to $300,000 [2]. - Each unit includes one common share and one common share purchase warrant, with the warrant allowing the purchase of an additional share at an exercise price of $0.05 for 24 months [3]. Group 2: Use of Proceeds - The proceeds from the offering will be utilized for general working capital, advancing graphite processing technologies, and ongoing development related to battery initiatives [4]. Group 3: Company Overview - Volt Carbon Technologies is a publicly traded company focused on carbon science, energy storage, and green energy, with mining claims in Ontario, Quebec, and British Columbia [5].
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX
Newsfile· 2025-11-19 20:41
Core Viewpoint - Rosen Law Firm is encouraging investors of Telix Pharmaceuticals Ltd. to secure legal counsel before the January 9, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from February 21, 2025 to August 28, 2025 [1][5]. Group 1: Class Action Details - Investors who purchased Telix securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 9, 2026 [3][6]. - The lawsuit alleges that Telix made materially false and misleading statements regarding its prostate cancer therapeutic candidates and the quality of its supply chain, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and success in this area [4].
BYND INVESTIGATION: Beyond Meat, Inc. Investors that Suffered Losses are Notified to Contact BFA Law about the Ongoing Securities Fraud Investigation
Newsfile· 2025-11-19 20:36
Core Viewpoint - Beyond Meat, Inc. is under investigation for potential violations of federal securities laws, particularly concerning the inflation of the value of certain long-lived assets [2][5]. Group 1: Company Operations and Financials - Beyond Meat underwent a global operations review in late 2023, leading to the depreciation of certain long-lived assets, which were recorded at the lower of their carrying value or fair value less costs to sell, with no impairments reported [4]. - On October 24, 2025, Beyond Meat announced an expected non-cash impairment charge for the three months ended September 27, 2025, related to certain long-lived assets, which was anticipated to be material [6]. - The company delayed its earnings announcement for Q3 2025 on November 3, 2025, due to the need for additional time to complete the impairment review, resulting in a significant decline in stock price during that trading day [7]. Group 2: Stock Performance - Following the announcement of the expected impairment charge, Beyond Meat's stock price dropped approximately 23%, from $2.84 per share on October 23, 2025, to $2.185 per share on October 24, 2025 [6].
INSP LAWSUIT: Inspire Medical Systems, Inc. Investors are Notified to Contact BFA Law about the Filed Securities Fraud Class Action and Important January 5 Deadline
Newsfile· 2025-11-19 20:36
Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Company Overview - Inspire Medical Systems, Inc. develops and manufactures an implantable medical device for the treatment of sleep apnea, with its latest product being the Inspire V, which received FDA approval on August 2, 2024 [4]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, which was supposed to meet high demand [5]. - Contrary to these assurances, Inspire allegedly failed to prepare clinicians and payors adequately, leading to significant delays in the device's adoption and weak demand due to excess inventory of older devices [6]. Stock Performance and Impact - On August 4, 2025, Inspire announced that the launch of Inspire V would face an "elongated timeframe," resulting in a reduction of its 2025 earnings per share guidance by over 80% [7]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].